Important Safety Information for Rheumatologists About Risks in Patients Receiving ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist that has been approved by the Food and Drug Administrati

First Page		Document Content
Date: 2015-06-21 12:11:52		Important Safety Information for Rheumatologists About Risks in Patients Receiving ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist that has been approved by the Food and Drug Administrati Add to Reading List Source URL: www.actemrahcp.com Download Document from Source Website File Size: 900,05 KB Share Document on Facebook